OppenheimerFunds’s Dr. Reddy's Laboratories RDY Stock Holding History

OppenheimerFunds’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-535,195	Closed	-$4.85M	–	1885
2016 Q4	$4.85M	Buy	535,195 +430,195	+410%	+$4M	0.01%	836
2016 Q3	$975K	Hold	105,000	–	–	﹤0.01%	1027
2016 Q2	$1.08M	Sell	105,000 -90,540	-46%	-$830K	﹤0.01%	983
2016 Q1	$1.77M	Buy	195,540 +6,000	+3%	+$53.6K	﹤0.01%	897
2015 Q4	$1.75M	Buy	189,540 +18,000	+10%	+$197K	﹤0.01%	915
2015 Q3	$2.19M	Buy	171,540 +5,500	+3%	+$68.3K	﹤0.01%	856
2015 Q2	$1.84M	Buy	166,040 +14,000	+9%	+$155K	﹤0.01%	879
2015 Q1	$1.74M	Buy	152,040 +89,000	+141%	+$944K	﹤0.01%	866
2014 Q4	$636K	Buy	63,040 +5,040	+9%	+$53.1K	﹤0.01%	888
2014 Q3	$610K	Buy	+58,000	New	+$545K	﹤0.01%	880

Other funds holding RDY

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OppenheimerFunds's RDY Position: Q1 2017 in Review

OppenheimerFunds sold out of Dr. Reddy's Laboratories (RDY) in Q1 2017, closing a stake of 535,195 shares — an estimated $4.85M sold.

OppenheimerFunds first reported a position in RDY in Q3 2014 and held it in 10 quarters. The position peaked at $4.85M in Q4 2016. 134 funds tracked by Wall St. Rank hold RDY as of Q1 2017.

OppenheimerFunds reported no remaining Dr. Reddy's Laboratories position as of Q1 2017 after selling out during the quarter.
OppenheimerFunds sold 535,195 Dr. Reddy's Laboratories shares in Q1 2017, an estimated $4.85M.
OppenheimerFunds first reported a position in Dr. Reddy's Laboratories in Q3 2014 and held it in 10 quarters.
OppenheimerFunds's Dr. Reddy's Laboratories position peaked at $4.85M in Q4 2016.
134 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2017.

Based on OppenheimerFunds's 13F filing for Q1 2017, filed 11 May 2017.